Bonus: Jeremy Levin

A conversation with Jeremy Levin, chairman of the Biotechnology Innovation Organization and CEO of Ovid Therapeutics, about industry versus government responses to covid19, the split within biotech on how to address charges of high prices, and why the biopharma industry is so disliked. 

Hosted on Acast. See acast.com/privacy for more information.

More from First Rounders

  1. 04:28Good ByeMay 04, 2022
  2. 01:11:46Jay KeaslingApr 01, 2022
  3. 01:03:22Ingmar HoerrFeb 01, 2022
  4. 52:17Lita NelsenDec 01, 2021
  5. 33:47Hope Lies in Dreams Chapter 1Sep 08, 2021
  6. 01:06:05Anthony AtalaSep 01, 2021
  7. 01:07:45Nancy SimonianJul 01, 2021
  8. 01:05:11Carl JuneJun 01, 2021
  9. 01:12:02Craig MelloMay 01, 2021
  10. 01:01:04Neil KumarMar 01, 2021